XML 22 R80.htm IDEA: XBRL DOCUMENT v2.3.0.15
Earnings Per Common Share Computation (Detail Supporting The Computation Of Basic And Diluted Earnings Per Common Share) (Details) (USD $)
In Thousands, except Per Share data
3 Months Ended12 Months Ended
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2009
Sep. 30, 2009
Jun. 30, 2009
Mar. 31, 2009
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Net income available for common stockholders$ 107,325[1]$ 393,221$ 340,076[2]$ 258,768$ 250,659$ 301,519$ 281,780$ 205,717$ 1,099,390$ 1,039,675$ 647,154
Weighted average outstanding shares of common stock used to compute basic earnings per common share        167,782167,364167,172
Shares used to compute diluted earnings per common share        169,798169,071169,187
Basic earnings per common share$ 0.64[1]$ 2.35$ 2.02[2]$ 1.54$ 1.49$ 1.80$ 1.68$ 1.23$ 6.55$ 6.21$ 3.87
Diluted earnings per common share$ 0.63[1]$ 2.32$ 2.00[2]$ 1.52$ 1.48$ 1.78$ 1.67$ 1.22$ 6.47$ 6.15$ 3.83
Employee Stock Option [Member]
           
Dilutive effect of employee stock options and restricted stock awards        6766771,173
Restricted Stock [Member]
           
Dilutive effect of employee stock options and restricted stock awards        1,3401,030842
[1]Includes an expense of $138.9 million ($88.0 million after tax, or $0.52 per diluted common share) associated with reserve strengthening for our closed block of long-term care policies acquired in connection with the 2007 acquisition of KMG America Corporation as more fully described in Note 18 to the consolidated financial statements.
[2]Includes an expense of $147.5 million ($93.4 million after tax, or $0.55 per diluted common share) for the write-down of deferred acquisition costs associated with our individual major medical policies as more fully described in Note 18 to the consolidated financial statements.